Seattle biotech companies are using AI to design new medical treatments, but scientists caution the tech holds enormous promise, but needs to stay grounded in reality.

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

AI helps speed up the process by proposing combinations of ingredients people haven’t thought of before, say the researchers.

Researchers at Harvard Medical School developed a tool that could use artificial intelligence to accelerate drug discovery ...

Biomedical engineers at Duke University have developed a platform that combines automated wet lab techniques with artificial intelligence (AI) to design nanoparticles for drug delivery. The approach ...

New antiviral drugs in development could offer the strongest line of defense yet against COVID-19 and other coronaviruses, ...

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant ...

GUEST COMMENTARY—For millions of patients, the slow pace of drug discovery means years – sometimes decades – without effective treatments. Many diseases remain untreatable, not because they are rare ...

Breast and Gynecologic Cancer Care for Sexual Minority Women and Transgender People The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.